• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COPD 形态发病机制的洞察:慢性炎症、重塑和抗菌防御。

An Insight into COPD Morphopathogenesis: Chronic Inflammation, Remodeling, and Antimicrobial Defense.

机构信息

Department of Morphology, Institute of Anatomy and Anthropology, Riga Stradins University, Kronvalda Boulevard 9, LV-1010 Riga, Latvia.

Pauls Stradins Clinical University Hospital, Pilsonu street 13, LV-1002 Riga, Latvia.

出版信息

Medicina (Kaunas). 2019 Aug 17;55(8):496. doi: 10.3390/medicina55080496.

DOI:10.3390/medicina55080496
PMID:31426487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6723364/
Abstract

Intercellular signaling networks with high complexity cause a spectrum of mechanisms achieving chronic obstructive pulmonary disease (COPD) that still question many uncertainties. Immunoreactive cells in bronchial tissue obtained from 40 COPD patients and 49 healthy control subjects were detected by biotin-streptavidin immunohistochemistry method for the following markers of IL-1α, IL-4, IL-6, IL-7, IL-8, IL-10, IL-12, TNF-α, MMP-2, TIMP-2, TGF-β1, Hsp-70, hBD-2, hBD-3, hBD-4. Overall the highest numbers (from mostly moderate (++) to abundance (++++)) of IL-1α, IL-4, IL-7, IL-8, IL-10, IL-12, MMP-2, TIMP-2, TGF-β1 immunoreactive cells were marked increasingly in the blood vessel wall, connective tissue, and bronchial epithelium of COPD-affected lung, respectively. We found statistically significant ( < 0.05) higher numbers of immunoreactive cells positive for all of examined interleukins, TNF-α, MMP-2, TIMP-2, TGF-β1, hBD-2, and hBD-3 in the COPD-affected lung compared to the control group, but not for Hsp-70 and hBD-4. COPD-affected lung tissue exhibits mostly inflammatory response patterns of increased IL-1α, IL-4, IL-8, IL-12, and TNF-α, especially in the airway epithelium. Increased MMP-2 and TGF-β1, but decreased Hsp-70, proposes pronounced tissue damage and remodeling in COPD. High numbers of hBD-2 and hBD-3 immunoreactive cells may highlight antimicrobial activity in COPD within stable regulation of local immunity.

摘要

细胞间信号网络具有高度复杂性,导致慢性阻塞性肺疾病(COPD)的机制谱仍存在许多不确定性。采用生物素-链霉亲和素免疫组织化学方法检测 40 例 COPD 患者和 49 例健康对照者支气管组织中的免疫反应细胞,用于 IL-1α、IL-4、IL-6、IL-7、IL-8、IL-10、IL-12、TNF-α、MMP-2、TIMP-2、TGF-β1、Hsp-70、hBD-2、hBD-3、hBD-4 的以下标志物。总体而言,IL-1α、IL-4、IL-7、IL-8、IL-10、IL-12、MMP-2、TIMP-2、TGF-β1 免疫反应细胞的数量(大多为中度(++)至丰富(++++))在 COPD 受累肺的血管壁、结缔组织和支气管上皮中分别呈递增趋势。我们发现,与对照组相比,COPD 受累肺中所有检查的白细胞介素、TNF-α、MMP-2、TIMP-2、TGF-β1、hBD-2 和 hBD-3 的免疫反应细胞数量均有统计学意义(<0.05)增加,但 Hsp-70 和 hBD-4 则不然。COPD 受累肺组织表现出以增加的 IL-1α、IL-4、IL-8、IL-12 和 TNF-α为主的炎症反应模式,尤其是在气道上皮中。MMP-2 和 TGF-β1 的增加,而 Hsp-70 的减少,提示 COPD 中存在明显的组织损伤和重塑。大量 hBD-2 和 hBD-3 免疫反应细胞可能突出了 COPD 中局部免疫稳定的抗菌活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf4/6723364/1651f1d15750/medicina-55-00496-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf4/6723364/1651f1d15750/medicina-55-00496-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf4/6723364/1651f1d15750/medicina-55-00496-g001a.jpg

相似文献

1
An Insight into COPD Morphopathogenesis: Chronic Inflammation, Remodeling, and Antimicrobial Defense.COPD 形态发病机制的洞察:慢性炎症、重塑和抗菌防御。
Medicina (Kaunas). 2019 Aug 17;55(8):496. doi: 10.3390/medicina55080496.
2
The evaluation of inflammatory, anti-inflammatory and regulatory factors contributing to the pathogenesis of COPD in airways.评估在气道中导致慢性阻塞性肺疾病发病机制的炎症、抗炎和调节因子。
Pathol Res Pract. 2019 Jan;215(1):97-105. doi: 10.1016/j.prp.2018.10.029. Epub 2018 Oct 29.
3
[Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].[哮喘和慢性阻塞性肺疾病患者诱导痰中金属蛋白酶-9/金属蛋白酶组织抑制剂-1及其与气道炎症和气流受限的关系]
Zhonghua Jie He He Hu Xi Za Zhi. 2007 Mar;30(3):192-6.
4
Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.慢性阻塞性肺疾病、特发性肺纤维化患者及健康受试者痰液中基质金属蛋白酶-9、金属蛋白酶组织抑制剂-1及其摩尔比
Respir Med. 2003 Jun;97(6):634-9. doi: 10.1053/rmed.2003.1493.
5
Role of aberrant metalloproteinase activity in the pro-inflammatory phenotype of bronchial epithelium in COPD.异常金属蛋白酶活性在 COPD 支气管上皮细胞促炎表型中的作用。
Respir Res. 2011 Aug 23;12(1):110. doi: 10.1186/1465-9921-12-110.
6
Enhanced expression of human β-defensin 2 in peripheral lungs of patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者外周肺中人类β-防御素 2 的表达增强。
Peptides. 2012 Dec;38(2):350-6. doi: 10.1016/j.peptides.2012.09.013. Epub 2012 Sep 19.
7
Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.慢性阻塞性肺疾病严重程度与潜在生物标志物的相关性。
Immunol Lett. 2018 Apr;196:1-10. doi: 10.1016/j.imlet.2018.01.004. Epub 2018 Jan 9.
8
[Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease].[慢性阻塞性肺疾病患者肺组织中细胞间黏附分子-1、金属蛋白酶组织抑制剂-1及基质金属蛋白酶-9表达之间的关系]
Zhonghua Jie He He Hu Xi Za Zhi. 2008 Feb;31(2):129-33.
9
Increased production of TGF-β1 from sputum cells of COPD: Relationship with airway obstruction.COPD 患者痰细胞中 TGF-β1 的产生增加:与气道阻塞的关系。
Cytokine. 2017 Nov;99:1-8. doi: 10.1016/j.cyto.2017.06.018. Epub 2017 Jun 29.
10
Expression of transforming growth factor beta1 in bronchial biopsies in asthma and COPD.哮喘和慢性阻塞性肺疾病患者支气管活检中转化生长因子β1的表达
J Asthma. 2003 Dec;40(8):887-93. doi: 10.1081/jas-120023580.

引用本文的文献

1
The Emerging Biomarkers in Chronic Obstructive Pulmonary Disease: A Narrative Review.慢性阻塞性肺疾病中的新兴生物标志物:一项叙述性综述
Diagnostics (Basel). 2025 May 14;15(10):1245. doi: 10.3390/diagnostics15101245.
2
as an Alternative Model to Higher Organisms for In Vivo Lung Research.作为一种替代高等生物的体内肺研究模型。
Int J Mol Sci. 2024 Sep 25;25(19):10324. doi: 10.3390/ijms251910324.
3
Local Defense Factors in Cleft-Affected Palate in Children before and during Milk Dentition Age: A Pilot Study.乳牙列期及乳牙列期前后儿童腭裂局部防御因素的初步研究

本文引用的文献

1
IL-33 Mediated Inflammation in Chronic Respiratory Diseases-Understanding the Role of the Member of IL-1 Superfamily.IL-33 在慢性呼吸系统疾病中的炎症作用——解析 IL-1 超家族成员的角色
Front Immunol. 2019 Apr 16;10:692. doi: 10.3389/fimmu.2019.00692. eCollection 2019.
2
COPD as a Disease of Immunosenescence.慢性阻塞性肺疾病作为一种免疫衰老疾病
Yonsei Med J. 2019 May;60(5):407-413. doi: 10.3349/ymj.2019.60.5.407.
3
Inflammatory Cytokines and T-Lymphocyte Subsets in Serum and Sputum in Patients with Bronchial Asthma and Chronic Obstructive Pulmonary Disease.
J Pers Med. 2023 Dec 25;14(1):27. doi: 10.3390/jpm14010027.
4
The Nicotinic Receptor Polymorphism rs16969968 Is Associated with Airway Remodeling and Inflammatory Dysregulation in COPD Patients.尼古丁受体多态性 rs16969968 与 COPD 患者的气道重塑和炎症失调有关。
Cells. 2022 Sep 20;11(19):2937. doi: 10.3390/cells11192937.
5
Effective-Component Compatibility of Bufei Yishen Formula III Combined with Electroacupuncture Suppresses Inflammatory Response in Rats with Chronic Obstructive Pulmonary Disease via Regulating SIRT1/NF-B Signaling.补肺益肾方 III 联合电针对慢性阻塞性肺疾病大鼠炎症反应的抑制作用及其调控 SIRT1/NF-κB 信号通路的研究
Biomed Res Int. 2022 May 9;2022:3360771. doi: 10.1155/2022/3360771. eCollection 2022.
6
Journal Club: Biologics and Potential for Immune Modulation in Chronic Obstructive Lung Disease.期刊俱乐部:生物制剂与慢性阻塞性肺疾病免疫调节的潜力
Chronic Obstr Pulm Dis. 2022 Apr 29;9(2):285-297. doi: 10.15326/jcopdf.2022.0318.
7
Distribution and Appearance of Ki-67, IL-1α, IL-10, and PGP 9.5 in Reinke's Oedema-Affected Larynx Tissue Compared with Control Tissue.与对照组织相比,Ki-67、IL-1α、IL-10和PGP 9.5在声带水肿累及的喉组织中的分布及表现
Life (Basel). 2021 Dec 10;11(12):1379. doi: 10.3390/life11121379.
8
SSRIs: Applications in inflammatory lung disease and implications for COVID-19.SSRIs:在炎症性肺病中的应用及对 COVID-19 的影响。
Neuropsychopharmacol Rep. 2021 Sep;41(3):325-335. doi: 10.1002/npr2.12194. Epub 2021 Jul 13.
9
miR-937 serves as an inflammatory inhibitor in cigarette smoke extract-induced human bronchial epithelial cells by targeting IL1B and regulating TNF-α/IL-17 signaling pathway.微小RNA-937通过靶向白细胞介素1β并调节肿瘤坏死因子-α/白细胞介素-17信号通路,在香烟烟雾提取物诱导的人支气管上皮细胞中作为一种炎症抑制剂发挥作用。
Tob Induc Dis. 2021 Jun 25;19:55. doi: 10.18332/tid/138227. eCollection 2021.
10
Association of Plasma Heat Shock Protein 70 with Disease Severity, Smoking and Lung Function of Patients with Chronic Obstructive Pulmonary Disease.血浆热休克蛋白70与慢性阻塞性肺疾病患者疾病严重程度、吸烟及肺功能的关系
J Clin Med. 2020 Sep 25;9(10):3097. doi: 10.3390/jcm9103097.
支气管哮喘和慢性阻塞性肺疾病患者血清和痰中的炎症细胞因子和 T 淋巴细胞亚群。
Med Sci Monit. 2019 Mar 25;25:2206-2210. doi: 10.12659/MSM.913703.
4
Basophils trigger emphysema development in a murine model of COPD through IL-4-mediated generation of MMP-12-producing macrophages.嗜碱性粒细胞通过 IL-4 介导的 MMP-12 产生巨噬细胞引发 COPD 小鼠模型的肺气肿发展。
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13057-13062. doi: 10.1073/pnas.1813927115. Epub 2018 Dec 3.
5
TGF-β: Master regulator of inflammation and fibrosis.转化生长因子-β:炎症与纤维化的主要调节因子。
Respirology. 2018 Dec;23(12):1096-1097. doi: 10.1111/resp.13415. Epub 2018 Oct 4.
6
Pro-inflammatory effects of extracellular Hsp70 and cigarette smoke in primary airway epithelial cells from COPD patients.COPD 患者原代气道上皮细胞细胞外 Hsp70 和香烟烟雾的促炎作用。
Biochimie. 2019 Jan;156:47-58. doi: 10.1016/j.biochi.2018.09.010. Epub 2018 Sep 27.
7
TGF-β Signaling in Lung Health and Disease.TGF-β 信号在肺部健康和疾病中的作用。
Int J Mol Sci. 2018 Aug 20;19(8):2460. doi: 10.3390/ijms19082460.
8
Over-expression of nuclear factor-κB family genes and inflammatory molecules is related to chronic obstructive pulmonary disease.核因子-κB家族基因和炎症分子的过度表达与慢性阻塞性肺疾病相关。
Int J Chron Obstruct Pulmon Dis. 2018 Jul 12;13:2131-2138. doi: 10.2147/COPD.S164151. eCollection 2018.
9
Changes in Th1/Th2-producing cytokines during acute exacerbation chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期Th1/Th2产生细胞因子的变化
J Int Med Res. 2018 Sep;46(9):3890-3902. doi: 10.1177/0300060518781642. Epub 2018 Jun 27.
10
Targeting cytokines to treat asthma and chronic obstructive pulmonary disease.针对细胞因子治疗哮喘和慢性阻塞性肺疾病。
Nat Rev Immunol. 2018 Jul;18(7):454-466. doi: 10.1038/s41577-018-0006-6.